These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38807383)

  • 1. CENTRALIZATION AND CORRUPTION IN HEALTH PROCUREMENT OF THE SOUTHERN EUROPEAN UNION COUNTRIES.
    Geropoulos N; Voultsos P; Geropoulos M; Tsolaki F; Tagarakis G
    Georgian Med News; 2024 Mar; (348):10-21. PubMed ID: 38807383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid model: a promising type of public procurement in the healthcare sector of the European Union.
    Geropoulos N; Voultsos P; Geropoulos M; Tsolaki F; Tagarakis G
    Front Public Health; 2024; 12():1359155. PubMed ID: 38425461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PREVENTION OF CORRUPTION OFFENCES IN THE HEALTHСARE: THE EXPERIENCE OF UKRAINE AND GEORGIA].
    Didkivska G; Kovalenko V; Fialka M; Samotiievych V; Sabadash I
    Georgian Med News; 2020 Nov; (308):185-191. PubMed ID: 33395665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 5. [MECHANISM OF PUBLIC PROCUREMENTS IN THE HEALTHCARE SPHERE IN THE EUROPEAN UNION AND UKRAINE: FINANCIAL AND LEGAL ASPECT].
    Dmytrenko E; Kharchenko V; Shcherbakovskyi M; Ozerskyi I; Popovich E
    Georgian Med News; 2019 Jun; (291):130-136. PubMed ID: 31418746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corruption and Population Health in the European Union Countries-An Institutionalist Perspective.
    Socoliuc Guriță OR; Sîrghi N; Jemna DV; David M
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUBLIC PROCUREMENT IN THE HEALTHCARE SECTOR: ADAPTATION OF THE ADMINISTRATIVE LEGISLATION OF UKRAINE TO THE EU LEGISLATION.
    Deshko L; Bysaga Y; Bysaga Y
    Georgian Med News; 2019 Jun; (291):126-130. PubMed ID: 31418745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corruption In Health Care Systems: Trends In Informal Payments Across Twenty-Eight EU Countries, 2013-19.
    Dallera G; Palladino R; Filippidis FT
    Health Aff (Millwood); 2022 Sep; 41(9):1342-1352. PubMed ID: 36067438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What factors influence smoking prevalence and smoke free policy enactment across the European Union Member States.
    Bogdanovica I; McNeill A; Murray R; Britton J
    PLoS One; 2011; 6(8):e23889. PubMed ID: 21909375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging European immigration regime: some reflections on implications for southern Europe.
    Baldwin-edwards M
    J Common Mark Stud; 1997 Dec; 35(4):497-519. PubMed ID: 12293846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral healthcare systems in the extended European union.
    Widström E; Eaton KA
    Oral Health Prev Dent; 2004; 2(3):155-94. PubMed ID: 15641621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food procurement. Making a meal of it.
    Jochelson K
    Health Serv J; 2003 Mar; 113(5846):24-6. PubMed ID: 12655866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 14. Greece: Health system review.
    Economou C
    Health Syst Transit; 2010; 12(7):1-177, xv-xvi. PubMed ID: 21330233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COUNTERACTION TO CORRUPTION DURING PUBLIC PROCUREMENT OF MEDICINAL PRODUCTS].
    Lohvynenko B; Podoliaka A; Domin Y; Kolesnikova I; Salaieva K
    Georgian Med News; 2022 Feb; (323):175-179. PubMed ID: 35271492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding public procurement within the health sector: a priority in a post-COVID-19 world.
    García-Altés A; McKee M; Siciliani L; Barros PP; Lehtonen L; Rogers H; Kringos D; Zaletel J; De Maeseneer J
    Health Econ Policy Law; 2023 Apr; 18(2):172-185. PubMed ID: 35894208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralised Pharmaceutical Procurement: Learnings from Six European Countries.
    Vogler S; Bauer E; Habimana K
    Appl Health Econ Health Policy; 2022 Sep; 20(5):637-650. PubMed ID: 35513686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-Government Attempts in Small Island Developing States: The Rate of Corruption with Virtualization.
    Sari A
    Sci Eng Ethics; 2017 Dec; 23(6):1673-1688. PubMed ID: 27995444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.